Forte Biosciences, Inc.

NasdaqCM:FBRX 주식 보고서

시가총액: US$6.1m

Forte Biosciences 대차 대조표 상태

재무 상태 기준 확인 4/6

Forte Biosciences has a total shareholder equity of $17.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $26.1M and $9.1M respectively.

주요 정보

0%

부채 비율

US$0

부채

이자 보상 비율n/a
현금US$24.50m
주식US$16.96m
총 부채US$9.12m
총 자산US$26.08m

최근 재무 상태 업데이트

Recent updates

We're A Little Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn Rate

Jul 17
We're A Little Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn Rate

Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans?

Mar 14
Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans?

Large Forte Biosciences shareholder scolds company board of directors

Aug 24

We're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash Wisely

Aug 17
We're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash Wisely

Forte Biosciences: Lots Of Clinical Risk Ahead And A Questionable Business Plan

Aug 16

Forte Biosciences large shareholders make demands for company's future

Jul 07

We Think Forte Biosciences (NASDAQ:FBRX) Needs To Drive Business Growth Carefully

Dec 23
We Think Forte Biosciences (NASDAQ:FBRX) Needs To Drive Business Growth Carefully

Forte Biosciences files for $300M mixed shelf offering

May 28

Are Insiders Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Stock?

Mar 13
Are Insiders Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Stock?

Do Institutions Own Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Jan 19
Do Institutions Own Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Forte Biosciences: FB-401 Potentially Best-In-Class In Atopic Dermatitis

Dec 18

Who Has Been Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Nov 25
Who Has Been Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Forte Biosciences readies equity offering

Oct 28

재무 상태 분석

단기부채: FBRX's short term assets ($25.7M) exceed its short term liabilities ($9.1M).

장기 부채: FBRX has no long term liabilities.


부채 대 자본 내역 및 분석

부채 수준: FBRX is debt free.

부채 감소: FBRX has not had any debt for past 5 years.


대차 대조표


현금 런웨이 분석

과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.

안정적인 현금 활주로: FBRX has less than a year of cash runway based on its current free cash flow.

예측 현금 활주로: FBRX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 25.9% each year


건강한 기업 발견하기